Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016

Details for Mechanism ID: 16884
Country/Region: Tanzania
Year: 2013
Main Partner: Drug Control Commission - Tanzania
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $250,000

The purpose of this program is to provide coordination, guidance, oversight and support for HIV testing, prevention, and care and treatment for people who use drugs (PWUD) and people who inject drugs (PWID) in Tanzania Mainland.

Objectives:

1. To advocate for and facilitate integration of evidence based strategies for HIV testing, prevention, and care and treatment for people who use drugs in relevant policies and guidelines and to coordinate technical assistance (TA) with national and international collaborators.

2. To provide and track resources and services for HIV testing, prevention and care for PWUD and PWID, in collaboration with Ministry of Health and other stakeholders through appropriate monitoring and evaluation systems to ensure sustained essential services in prioritized locations in the country.

3. To coordinate stakeholders through development and regular review of research plans, including PWUD and PWID surveillance, size estimations and special studies conducted in Tanzania to increase evidence and data available about drug use in the country and facilitate dissemination and utilization of aquired information to prevent duplication of efforts among stakeholders.

Through this program, Tanzanian government stakeholders receive technical support to establish an enabling environment for a public health approach to addressing substance abuse as a contributor to HIV in the country. Having overcome the heavier initial investments towards these interventions, the Tanzania government will be in a position to sustain the program using local resources.

Funding for Prevention: Injecting and Non-Injecting Drug Use (IDUP): $250,000

It is estimated that there are at least 25,000 persons who inject drugs (PWID) in mainland Tanzania and many more persons who use drugs (PWUD) through other routes. Available data from Dar es Salaam, the commercial capital, indicate HIV prevalence of 42% among PWID compared to 11% among the general population in the city. Risky injection practices have been documented among PWID, such as sharing needles, coupled with risky sexual practices. HIV prevalence has been consistently higher among female PWUD and PWID coupled with trading sex for money and drugs, high numbers of sexual partners, inconsistent condom use, intimate partner violence, rape and alcohol abuse. This program targets PWUD and PWID where there are concentrated populations in Dar es Salaam and other parts of mainland Tanzania with specific initatives to strategically reach those at highest risk, such as females and those without a social support network.

The program aims to support the recommended nine-component comprehensive package of services for HIV prevention and care among PWID and PWUD with a focus on facilitating access to medication-assisted treatment for opioid addiction and other harm reduction initiatives, and facilitating linkages to and retention in HIV care and treatment for those found to be HIV positive.

The Tanzania Drug Control Commission serves a national coordination and quality assurance role, in collaboration with the approrpiate technical sector, for the interventions in collaboration with health service providers, academia and law-making and enforcement bodies.

Subpartners Total: $0
Pangaea Global AIDS Foundation: NA
Cross Cutting Budget Categories and Known Amounts Total: $250,000
Human Resources for Health $250,000
Key Issues Identified in Mechanism
Increase gender equity in HIV prevention, care, treatment and support